DC67601 · Updated 28 October 2026
Sanofi Lipid 15
Instructions for Use
Before use
Check the supplied lot number, batch COA, approved SDS, quantity and retest date. Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light.
For small quantities of viscous or oily lipid, volumetric transfer can reduce weighing losses. Confirm solvent compatibility and solubility before preparing a stock; calculated volumes do not establish solubility.
Stock-solution planning
Volume (mL) = mass (mg) × 1000 / [molecular weight × concentration (mM)].
| Mass | 10 mM | 20 mM |
|---|---|---|
| 10 mg | 1.0576 mL | 0.5288 mL |
| 25 mg | 2.6441 mL | 1.3220 mL |
| 50 mg | 5.2882 mL | 2.6441 mL |
| 100 mg | 10.5763 mL | 5.2882 mL |
Literature formulation reference
| Component | DC Chemicals product | Molecular weight | Molar ratio | Mass at 1 µmol total lipid (mg) |
|---|---|---|---|---|
| Sanofi Lipid 15 | DC67601 | 945.51 | 49 | 0.463300 |
| Cholesterol | DCD-041 | 386.65 | 39 | 0.150793 |
| DSPC | DC57005 | 790.15 | 10 | 0.079015 |
| DPG-PEG2000 | Not uniquely mapped | Not established | 2 | Not calculable from disclosed data |
Base lipid blend: Lipid 15/cholesterol/DSPC/DPG-PEG2000 = 49:39:10:2 mol%. DPG-PEG is not DMG-PEG2000; 2507 is therefore not assigned to it. The reported N/P design range is 4–6. CD8-targeting VHH conjugate is introduced separately and is not represented as a fifth prefilled bulk-lipid percentage.
Read the complete study conditions, biological results, tolerability and figures →